Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Epidemiol Infect ; 143(16): 3550-6, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25876626

RESUMEN

Obesity potentially arising from viral infection is known as 'infectobesity'. The latest reports suggest that adenovirus-36 (Adv36) is related to obesity in adults and children. Our aim was not only to determine the Adv36 seropositivity in both obese and non-obese children and adults, but also to investigate correlations between antibody positivity and serum lipid profiles. Both Adv36 positivity and tumour-necrosis-factor-alpha, leptin and interleukin-6 levels were detected in blood samples collected from 146 children and 130 adults by ELISA. Fasting plasma triglycerides, total cholesterol and low-density lipoprotein levels were also measured. Adv36 positivity was determined to be 27·1% and 6% in obese and non-obese children and 17·5% and 4% in obese and non-obese adults, respectively. There was no difference with regard to total cholesterol, low-density lipoprotein, triglyceride, tumour-necrosis-factor-alpha and interleukin-6 levels (P > 0·05). However, there was a significant difference between groups in terms of leptin levels (P < 0·05). We determined the prevalence of Adv36 positivity in obese children and adults. Our results showed that Adv36 may be an obesity agent for both adults and children, parallel with current literature data. However, the available data on a possible relationship between Adv36 infection and obesity both in children and adults do not completely solve the problem.


Asunto(s)
Infecciones por Adenoviridae/complicaciones , Infecciones por Adenoviridae/epidemiología , Adenovirus Humanos/aislamiento & purificación , Metaboloma , Obesidad/epidemiología , Obesidad/etiología , Adolescente , Adulto , Niño , Preescolar , Citocinas/sangre , Femenino , Humanos , Leptina/sangre , Lípidos/sangre , Masculino , Persona de Mediana Edad , Turquía/epidemiología
3.
J Int Med Res ; 30(5): 525-8, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12449523

RESUMEN

Fusidic acid is an antibiotic active against staphylococci and other bacterial pathogens. It is used in the treatment of staphylococcal infections usually in combination with other antibacterial agents. Reports of the clinical effects of antimicrobial combinations containing fusidic acid have been somewhat inconsistent. The aim of this study was to investigate the in vitro antagonism of fusidic acid and quinolones. Twenty-six staphylococci strains isolated from various clinical samples were tested. After detecting the diameter of the zone of inhibition around fusidic acid, levofloxacin, ciprofloxacin, ofloxacin and moxifloxacin for each strain, in vitro antagonism between fusidic acid and each quinolone was investigated using disk approximation. In all 26 strains, quinolones and fusidic acid were antagonist in vitro. The reason for this antagonistic effect and its clinical implications are not known. However, care should be exercised in prescribing quinolones and fusidic acid in combination.


Asunto(s)
Antibacterianos/administración & dosificación , Antibacterianos/antagonistas & inhibidores , Antiinfecciosos/administración & dosificación , Compuestos Aza , Fluoroquinolonas , Ácido Fusídico/administración & dosificación , Ácido Fusídico/antagonistas & inhibidores , Quinolinas , Staphylococcus/efectos de los fármacos , Ciprofloxacina/administración & dosificación , Humanos , Técnicas In Vitro , Levofloxacino , Pruebas de Sensibilidad Microbiana , Moxifloxacino , Ofloxacino/administración & dosificación , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/microbiología , Staphylococcus/aislamiento & purificación
5.
Int J Clin Pract ; 59(4): 437-40, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15853861

RESUMEN

Our object is to determine the prevalence of group B streptococcus (GBS) carriage among pregnant women, the neonatal colonisation rate and the antimicrobial susceptibility to formulate a policy for treatment and prevention regarding perinatal GBS diseases in eastern Turkey. A total of 150 pregnant women were screened for GBS colonisation. Samples were collected from the vagina and the rectum of pregnant women, and the ear canal, throat and umbilicus of the neonates of colonised mothers. Antimicrobial susceptibility of the isolates was also investigated. GBS was isolated in at least one specimen from the 150 women in 48 cases; it was estimated that, overall, about 32% of the pregnant women and 17.3% of overall newborns were colonised with GBS. The overall rate of GBS vertical transmission was 54.2% in this study. Maternal colonisation rate was significantly higher in younger ages (p < 0.01) when maternal age of 20 years was taken as a cut-off point. All isolates were found to be sensitive to penicillin, ampicillin, cefazolin and vancomycin. Resistance to erythromycin and clindamycin were found to be 13.5 and 2.7%, respectively.


Asunto(s)
Portador Sano/microbiología , Farmacorresistencia Bacteriana , Transmisión Vertical de Enfermedad Infecciosa , Complicaciones Infecciosas del Embarazo/epidemiología , Infecciones Estreptocócicas/epidemiología , Streptococcus agalactiae/aislamiento & purificación , Adolescente , Adulto , Peso al Nacer , Femenino , Política de Salud , Humanos , Recién Nacido , Persona de Mediana Edad , Embarazo , Complicaciones Infecciosas del Embarazo/tratamiento farmacológico , Prevalencia , Estudios Prospectivos , Factores de Riesgo , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/transmisión , Turquía/epidemiología
6.
Int J Clin Pract ; 58(12): 1112-4, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15646406

RESUMEN

Polysaccharide slime seems to be the most important factor by which coagulase negative staphylococci (CNS) strains adheres and colonises catheters. The aim of this study was to determine the prevalence of slime-producing CNS strains isolated from nasal samples of patients on haemodialysis and of healthy persons as a control. Nasal cultures were performed for 131 haemodialysis patients and 56 healthy persons. CNS strains were isolated from 86 of 131 patients (72.9%), and 46 of 56 healthy persons (82.1%). Twenty-four (27.9%) of the 86 CNS strains tested in the patient group and four (8.7%) of the 46 CNS strains in the control group were slime factor positive. There was a significant difference (p<0.01) in slime production between CNS strains isolated from haemodialysis patients and from control group. The detection of slime-producing coagulase-negative staphylococcus carriage in haemodialysis patients may prevent dialysis catheter-related coagulase-negative staphylococcal infections.


Asunto(s)
Catéteres de Permanencia/microbiología , Mucosa Nasal/microbiología , Polisacáridos Bacterianos/biosíntesis , Diálisis Renal/efectos adversos , Infecciones Estafilocócicas/prevención & control , Staphylococcus/metabolismo , Adolescente , Adulto , Anciano , Coagulasa , Farmacorresistencia Bacteriana , Contaminación de Equipos/prevención & control , Femenino , Humanos , Fallo Renal Crónico/terapia , Masculino , Persona de Mediana Edad , Factores de Riesgo , Staphylococcus/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda